ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 宜明昂科生物醫藥技術(上海)股份有限公司
Pay for financial year ended 2024-12-31
Source: Annual report
Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Supervisors |
||||||||
| 1 | Gu, Jiefeng 顧傑鋒 | Sup Ch | ||||||
| 2 | Tian, Miao (1992) 田苗 | Supervisor | 398 | 52 | 56 | 21 | 527 | |
| 3 | Zhang, Wei (ImmuneOnco) 張薇 | Supervisor | 582 | 79 | 70 | 26 | 757 | |
| 4 | Zhao, Zimeng 趙子萌 | Supervisor | 395 | 51 | 56 | 18 | 520 | |
| Total | 0 | 1,375 | 182 | 182 | 65 | 1,804 | ||
Directors |
||||||||
| 5 | Guan, Mei (1982) 關梅 | ED | 632 | 97 | 71 | 14 | 814 | |
| 6 | Li, Song (1985) 李松 | ED | 832 | 120 | 71 | 1,023 | ||
| 7 | Smith, Kendall Arthur | INED | 356 | 356 | ||||
| 8 | Song, Ziyi 宋子一 | FD | 376 | 167 | 3 | -3,102 | -2,556 | |
| 9 | Tian, Wenzhi (1964) 田文志 | Ch, CEO, Fdr | 2,939 | 660 | 87 | 21,969 | 25,655 | |
| 10 | Xu, Cong (1986) 徐聰 | NED | ||||||
| 11 | Yeung, Rex Chi Tat 楊志達 | INED | 274 | 274 | ||||
| 12 | Yu, Xiaoyong 于曉勇 | NED | ||||||
| 13 | Yu, Zhihua (1967) 余治華 | NED | ||||||
| 14 | Zhu, Zhenping 朱禎平 | INED | ||||||
| Total | 630 | 4,779 | 1,044 | 232 | 18,881 | 25,566 | ||
| Grand total | 630 | 6,154 | 1,226 | 414 | 18,946 | 27,370 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 630 | 4,779 | 1,044 | 232 | 18,881 | 25,566 | Report |
| 2023-12-31 | 623 | 5,856 | 1,055 | 168 | 43,236 | 50,938 | Report |
| Total | 1,253 | 10,635 | 2,099 | 400 | 62,117 | 76,504 |
Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!
Copyright & disclaimer, Privacy policy